For information about COVID-19, including symptoms and prevention, please read our COVID-19 patient guide. Please also consider supporting Weill Cornell Medicine’s efforts against the pandemic.

Prescription Drug Monitoring Program Mandates: Impact On Opioid Prescribing And Related Hospital Use.

TitlePrescription Drug Monitoring Program Mandates: Impact On Opioid Prescribing And Related Hospital Use.
Publication TypeJournal Article
Year of Publication2019
AuthorsWen H, Hockenberry JM, Jeng PJ, Bao Y
JournalHealth Aff (Millwood)
Volume38
Issue9
Pagination1550-1556
Date Published2019 Sep
ISSN1544-5208
Abstract

Comprehensive mandates for prescription drug monitoring programs (PDMPs) require state-licensed prescribers and dispensers both to register with and to use the programs in most clinical circumstances. Such mandates have the potential to improve providers' participation and reduce opioid-related adverse events. Using Medicaid prescription data and hospital utilization data across the US in the period 2011-16, we found that state implementation of comprehensive PDMP mandates was associated with a reduction in the opioid prescription rate from 161.47 to 147.07 per 1,000 enrollees per quarter, a reduction in the opioid-related inpatient stay rate from 97.50 to 93.34 per 100,000 enrollees per quarter, and a reduction in the opioid-related emergency department (ED) visit rate from 74.60 to 61.36 per 100,000 enrollees per quarter. Our estimated annual reductions of approximately 12,000 inpatient stays and 39,000 ED visits could save over $155 million in Medicaid spending, a fact that deserves policy attention when states attempt to strengthen and refine PDMPs to better tackle the opioid crisis.

DOI10.1377/hlthaff.2019.00103
Alternate JournalHealth Aff (Millwood)
PubMed ID31479368
Grant ListP30 DA040500 / DA / NIDA NIH HHS / United States
Division: 
Comparative Effectiveness & Outcomes Research
Category: 
Faculty Publication